Nutraceutical Interception of Cachexia: Grape-Derived Compounds as Pathophysiological Network Modulators

Area of Science:

• Oncology
• Nutritional Science
• Biochemistry

Background:

• Cancer cachexia is a complex metabolic syndrome causing muscle loss and poor outcomes in cancer patients.
• Current treatments for cancer cachexia are limited, necessitating novel therapeutic strategies.
• Grape seed polyphenols exhibit anti-inflammatory and metabolic regulatory properties relevant to cachexia.

Purpose of the Study:

• To review the evidence supporting grape seed-derived compounds in managing cancer cachexia.
• To explore the mechanisms of action, including effects on key signaling pathways and the gut-muscle axis.
• To discuss the potential of grape seed flour as a nutraceutical intervention.

Main Methods:

• Integration of preclinical and clinical evidence on grape seed polyphenols.
• Analysis of molecular targets such as NF-κB and AMPK pathways.
• Evaluation of nutritional composition and bioactive properties of grape seed flour.

Main Results:

• Grape seed polyphenols demonstrate potential to modulate catabolic signaling, mitochondrial dysfunction, and inflammation.
• Evidence suggests beneficial effects on redox homeostasis and the gut-muscle axis.
• Grape seed flour is rich in fiber and phenolic compounds, indicating nutraceutical value.

Conclusions:

• Grape-derived compounds represent a safe and mechanistically sound approach to improving nutritional status in cancer cachexia.
• Grape seed flour supplementation is being evaluated in a clinical trial for colorectal cancer patients with cachexia.
• These findings support the development of integrative strategies for oncological care.